Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-127842
Filing Date
2024-11-18
Accepted
2024-11-18 12:06:05
Documents
123
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rgen-20231231.htm   iXBRL 10-K/A 5197541
2 EX-23.1 rgen-ex23_1.htm EX-23.1 6782
3 EX-31.1 rgen-ex31_1.htm EX-31.1 13125
4 EX-31.2 rgen-ex31_2.htm EX-31.2 13116
5 EX-32.1 rgen-ex32_1.htm EX-32.1 16664
  Complete submission text file 0000950170-24-127842.txt   26387306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgen-20231231.xsd EX-101.SCH 2874873
126 EXTRACTED XBRL INSTANCE DOCUMENT rgen-20231231_htm.xml XML 6851798
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-14656 | Film No.: 241470430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)